From Casetext: Smarter Legal Research

Regenerative Sciences v. U.S. Food Drug Administration

United States District Court, D. Colorado
May 5, 2009
Civil Action No. 09-cv-00411-WYD-BNB (D. Colo. May. 5, 2009)

Opinion

Civil Action No. 09-cv-00411-WYD-BNB.

May 5, 2009


ORDER


Counsel appeared this morning for a scheduling conference. The defendants contend that this is an action for review on an administrative record and is exempt under Fed.R.Civ.P. 26(a)(1)(B)(i) from the initial disclosure requirements and under D.C.COLO.LCivR 16.2(B)(2) from the entry of a scheduling order for discovery. The plaintiff contends that there are factual matters and matters subject to the development of expert testimony which must be developed for presentation at a trial.

IT IS ORDERED that on or before May 20, 2009, the defendants shall file a motion seeking to exempt this case disclosures, discovery, and expert witnesses under Fed.R.Civ.P. 26(a)(1)(B)(i) and D.C.COLO.LCivR 16.2(B)(2). The plaintiff shall file a response on or before June 1, 2009.


Summaries of

Regenerative Sciences v. U.S. Food Drug Administration

United States District Court, D. Colorado
May 5, 2009
Civil Action No. 09-cv-00411-WYD-BNB (D. Colo. May. 5, 2009)
Case details for

Regenerative Sciences v. U.S. Food Drug Administration

Case Details

Full title:REGENERATIVE SCIENCES, INC. Plaintiff, v. UNITED STATES FOOD AND DRUG…

Court:United States District Court, D. Colorado

Date published: May 5, 2009

Citations

Civil Action No. 09-cv-00411-WYD-BNB (D. Colo. May. 5, 2009)